Cargando…

Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling

Compelling efficacy on intervention of tumorigenesis by nonsteroidal anti-inflammatory drugs (NSAIDs) has been documented intensively. However, the toxicities related to cyclooxygenase (COX) inhibition resulting in suppression of physiologically important prostaglandins limit their clinical use for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Bin, Chang, Hong, Ma, Ruixia, Feng, Xiangling, Li, Wei, Piazza, Gary A., Xi, Yaguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884969/ https://www.ncbi.nlm.nih.gov/pubmed/26769851 http://dx.doi.org/10.18632/oncotarget.6888

Ejemplares similares

Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats
por: Tinsley, Heather N., et al.
Publicado: (2023)

Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21
por: Zhou, Xue, et al.
Publicado: (2015)

Sulindac inhibits tumor cell invasion by suppressing NF-κB mediated transcription of microRNAs
por: Li, Xiaobo, et al.
Publicado: (2012)

Sulindac Derivatives That Activate the Peroxisome Proliferator-activated Receptor γ but Lack Cyclooxygenase Inhibition
por: Felts, Andrew S., et al.
Publicado: (2008)

Cyclooxygenase-1-Selective Inhibitors Based on the (E)-2′-Des-methyl-sulindac Sulfide Scaffold
por: Liedtke, Andy J., et al.
Publicado: (2012)

Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer
por: Hossain, Fokhrul, et al.
Publicado: (2023)

Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice
por: Bi, Xiuli, et al.
Publicado: (2013)

Cyclin G2, a novel target of sulindac to inhibit cell cycle progression in colorectal cancer
por: Zhao, Hongyou, et al.
Publicado: (2020)

Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023)

Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1
por: Cha, Byong-Ki, et al.
Publicado: (2016)

Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion
por: Whitt, Jason D., et al.
Publicado: (2016)

TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
por: Loboda, Agnieszka, et al.
Publicado: (2016)

Quercetin is able to alleviate TGF-β-induced fibrosis in renal tubular epithelial cells by suppressing miR-21
por: Cao, Yaochen, et al.
Publicado: (2018)

Sulindac for stroke treatment: neuroprotective mechanism and therapy
por: Modi, Jigar Pravinchandra, et al.
Publicado: (2014)

Amine Containing Analogs of Sulindac for Cancer Prevention
por: Mathew, Bini, et al.
Publicado: (2018)

Oxazole and thiazole analogs of sulindac for cancer prevention
por: Mathew, Bini, et al.
Publicado: (2018)

miR-21 inhibits the effects of cyclooxygenase-2 inhibitor NS398 on apoptosis and invasion in gastric cancer cells
por: Li, Huanqing, et al.
Publicado: (2015)

Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development
por: Davis, Jennifer S., et al.
Publicado: (2020)

The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma
por: Humbert, Laure, et al.
Publicado: (2015)

Cyclooxygenase-2 overexpression abrogates the antiproliferative effects of TGF-β
por: Enders, G A
Publicado: (2007)

MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation
por: Li, Qiong, et al.
Publicado: (2013)

Targets of miR-200c mediate suppression of cell motility and anoikis resistance
por: Howe, Erin N, et al.
Publicado: (2011)

Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression
por: Larkins, Teri L, et al.
Publicado: (2006)

HBV induces liver fibrosis via the TGF-β1/miR-21-5p pathway
por: Li, Wenting, et al.
Publicado: (2021)

The effects of the miR-21/SMAD7/TGF-β pathway on Th17 cell differentiation in COPD
por: He, Shengyang, et al.
Publicado: (2021)

Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress
por: Marchetti, Maria, et al.
Publicado: (2009)

Sulindac Prevents Esophageal Adenocarcinomas Induced by Gastroduodenal Reflux in Rats
por: Kim, Sung Wook, et al.
Publicado: (2007)

A Desmoid Tumor Responding to Systemic Therapy With Tamoxifen and Sulindac
por: Choudhury, Hasan, et al.
Publicado: (2023)

Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors
por: Li, Xi, et al.
Publicado: (2015)

Anti-Amyloidogenic and Cyclooxygenase Inhibitory Activity of Guettarda speciosa
por: Tan, Mario A., et al.
Publicado: (2019)

MiR-378a suppresses tenogenic differentiation and tendon repair by targeting at TGF-β2
por: Liu, Yang, et al.
Publicado: (2019)

Inhibitory effects of oxymatrine on hepatic stellate cells activation through TGF-β/miR-195/Smad signaling pathway
por: Song, Li-Ying, et al.
Publicado: (2019)

miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-β Signaling
por: Huang, Shuai, et al.
Publicado: (2019)

MiR‐195 and miR‐497 suppress tumorigenesis in lung cancer by inhibiting SMURF2‐induced TGF‐β receptor I ubiquitination
por: Chae, Dong‐Kyu, et al.
Publicado: (2019)

Sulindac metabolites inhibit epidermal growth factor receptor activation and expression
por: Pangburn, Heather A, et al.
Publicado: (2005)

Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage
por: Ayyanathan, Kasirajan, et al.
Publicado: (2012)

Sulindac activates NF-κB signaling in colon cancer cells
por: Mladenova, Dessislava, et al.
Publicado: (2013)

Analysis of the Dissolution Mechanism of Drugs into Polymers: The Case of the PVP/Sulindac System
por: Latreche, Mansour, et al.
Publicado: (2023)

MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells
por: Zhang, Wei, et al.
Publicado: (2015)

Tumor suppression by miR-31 in esophageal carcinoma is p21-dependent
por: Ning, Zhifeng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gas4f7c79kgeej3nckok84gkq2